ÈËÉú¾ÍÊDz©

EN
ÈËÉú¾ÍÊDz©_Ê×Ò³Èë¿Ú ÈËÉú¾ÍÊDz©_Ê×Ò³Èë¿Ú
ÐÂÎÅÖÐÐÄ
2024-07-15
ÎÒ¹ú¿ÆÑÐÍŶÓÊ״ι¹½¨·º°©ÖÖÂö¹ÜϵͳȫϢϸ°ûͼÆ×
¿ËÈÕ£¬£¬ÖØÇì´óѧӡÃ÷Öù½ÌÊÚÍŶÓÔÚ¹ú¼ÊѧÊõÆÚ¿¯¡¶×ÔÈ»¡·½ÒÏþ×îÐÂÑо¿Ð§¹û¡£¡£¡£¡£¸ÃÑо¿Ê״ι¹½¨ÁË×î´ó¹æÄ£µÄ·º°©ÖÖÂö¹ÜϵͳȫϢϸ°ûͼÆ×£¬£¬Îª³äÇå³þÈ·Ö×ÁöѪ¹ÜÌìÉúµÄÖØ´óÀú³ÌÌṩÁËÈ«¾°Êӽǣ¬£¬Í¬Ê±ÎªÁÙ´²ÌáÉý¿¹Ñª¹ÜÌìÉúÖÎÁÆÁÆÐ§ÌṩÁË¿ÆÑ§¼Æ»®¡£¡£¡£¡£
ÔĶÁ¸ü¶à
2024-07-12
¸ÄÁ¼CAR-Tϸ°ûÁÆ·¨£¡×îÐÂScience×Ó¿¯Ñо¿£ºTOP CAR-Tϸ°ûÁÆ·¨ÔÚʵÌåÁöÖÎÁÆÁìÓò»ñµÃÖØ´óÍ»ÆÆ
ÔÚÒ»ÏîеÄÑо¿ÖУ¬£¬À´×Ô°¢¶û²®ÌØ-°®Òò˹̹ҽѧԺµÄÑо¿Ö°Ô±È¡µÃÁËÖØ´óÏ£Íû£¬£¬ËûÃÇ·¢Ã÷ÁËÒ»ÖÖ¸ÄÁ¼µÄCAR-Tϸ°ûÁÆ·¨£¬£¬¸ÃÁÆ·¨Õë¶ÔʵÌåÁöÕ¹ÏÖ³öÁËØ¨¹ÅδÓеÄÁÆÐ§£¬£¬ÕâһЧ¹û»ò½«ÖØËܰ©Ö¢ÖÎÁÆÃûÌᣡ£¡£¡£Ïà¹ØÑо¿Ð§¹û½üÆÚ½ÒÏþÔÚScience AdvancesÆÚ¿¯ÉÏ£¬£¬ÂÛÎÄÎÊÌâΪ¡°TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors¡±¡£¡£¡£¡£
ÔĶÁ¸ü¶à
2024-07-11
ÎÒ¿ÆÑÐÍŶӷ¢Ã÷Âѳ²°©ÃâÒßÖÎÁÆÐ°еã
¿ËÈÕ£¬£¬»ªÖпƼ¼´óѧͬ¼ÃÒ½ÔºÂí¶¡ÔºÊ¿¡¢¸ßÇìÀÙ½ÌÊÚ¡¢·½Ó½ÌÊÚÁªºÏÃÀ¹úÁºêϽÌÊÚÍŶÓͨ¹ýǰհÐÔÁÙ´²ÊÔÑéµÄ¶à×éѧÊý¾ÝÆÊÎö£¬£¬Ê×´ÎÕ¹ÏÖÁËÍ¬Ô´ÖØ×éÐÞ¸´È±ÏÝ£¨HRD£©ÓëÍêÕû£¨HRP£©Âѳ²°©ÔÚÖ×Áö΢ÇéÐβãÃæµÄ²î±ð¡£¡£¡£¡£Ïà¹ØÐ§¹ûÔÚÏß½ÒÏþÓÚ¡¶Ï¸°û¡·¡£¡£¡£¡£
ÔĶÁ¸ü¶à
2024-07-10
×è¶ÏTGF-¦ÂÐźÅ£¬£¬ÊÇiPSC-NKϸ°ûÖÎÁƸΰ©Ëù±ØÐèµÄ
2024Äê7ÔÂ9ÈÕ£¬£¬¼ÓÖÝ´óѧʥµØÑǸç·ÖУµÄÑо¿Ö°Ô±ÔÚCell×Ó¿¯Cell Stem CellÉϽÒÏþÁËÌâΪ£ºDisruption of TGF-¦Âsignaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cellsµÄÑо¿ÂÛÎÄ¡£¡£¡£¡£¸ÃÑо¿Åú×¢£¬£¬×è¶ÏTGF-¦ÂÐźÅ£¬£¬ÊÇÓÕµ¼¶àÐÑĿϸ°û£¨iPSC£©ÈªÔ´µÄ×ÔȻɱÉËϸ°û£¨iPSC-NK£©ÓÐÓÃÖÎÁƸÎϸ°û°©£¨HCC£©Ëù±ØÐèµÄ¡£¡£¡£¡£
ÔĶÁ¸ü¶à
2024-07-08
¾­Ë¢ÐºóÊÍ·ÅÖ×Áö°ÐÏò¿¹ÌåºÍÃâÒߴ̼¤¼ÁµÄ¦Ã¦ÄTϸ°ûÓÐÍûÖÎÁƹÇѪÁö
ÔÚÒ»ÏîеÄÑо¿ÖУ¬£¬À´×ÔÂ×¶Ø´óѧѧԺµÄÑо¿Ö°Ô±ÔÚСÊóÖз¢Ã÷ËûÃÇ¿ª·¢µÄÒ»ÖÖÐÂÐÍÏÔʾ³ö¶Ô¹ÇѪÁöÓкܺõÄÁÙ´²Ç°Ð§¹û¡£¡£¡£¡£Ïêϸ¶øÑÔ£¬£¬ËûÃÇʹÓÃһС²¿·ÖÃâÒßϸ°û£¬£¬¼´¦Ã¦ÄTϸ°û£¨gamma-delta T cell£©£¬£¬¿ÉÄÜÌṩһÖÖ¸ßЧ¡¢¾­¼ÃµÄÖÎÁƼƻ®¡£¡£¡£¡£
ÔĶÁ¸ü¶à
2024-07-04
²»ÔÐÖ¢Ñо¿»ñÖ÷ÒªÍ»ÆÆ£¡ÕâÖÖ¸Éϸ°û»ò³ÉΪ¡°ÊÔ¹ÜÓ¤¶ù¡±µÈÉúÓýÖÎÁƵÄÒªº¦
¿ËÈÕ£¬£¬µ¤Âó¸ç±¾¹þ¸ù´óѧµÄÑо¿ÍŶÓÔÚ?Cell?ÆÚ¿¯½ÒÏþÁËÌâΪ£ºThe primitive endoderm supports lineage plasticity to enable regulative development£¨Ô­Ê¼ÄÚÅß²ãÖ§³ÖÆ×ϵ¿ÉËÜÐÔ£¬£¬Ê¹µ÷¿Ø·¢Óý³ÉΪ¿ÉÄÜ£©µÄÑо¿ÂÛÎÄ¡£¡£¡£¡£¸ÃÑо¿Åú×¢£¬£¬Ò»ÖÖ±£´æÓÚÔçÆÚÅßÌ¥ÖеÄÄÜÐÔºÍÔÙÉú¸Éϸ°û¡ª¡ªÔ­Ê¼ÄÚÅ߲㣨Primitive Endoderm£¬£¬PrE£©£¬£¬¿ÉÒÔÔÚÊèÉ¢ºó×ÔÐб¬·¢ÅßÌ¥£¬£¬ÕâÒ»Í»ÆÆÐÔ·¢Ã÷»ò½«³ÉΪÖÎÁÆÈËÀ಻Ôв»ÓýµÄÒªº¦£¬£¬ÓÐÖúÓÚ¿ª·¢³ö¸üÀֳɵġ°ÊÔ¹ÜÓ¤¶ù¡±µÈÉúÓýÖÎÁÆ·½·¨¡£¡£¡£¡£
ÔĶÁ¸ü¶à
2024-07-03
CAR/TCR Tϸ°ûÁÆ·¨£ºÓÅ»¯Éú²úÒÔ½µµÍ±¾Ç®²¢Ìá¸ß¿É¼°ÐÔ
Ìá¸ßÉú²úЧÂʹØÓÚÀ©´óÉú²ú¹æÄ£¡¢½µµÍ±¾Ç®²¢Ìá¸ßCAR/TCR Tϸ°ûÁÆ·¨µÄ¿É¼°ÐÔÖÁ¹ØÖ÷Òª¡£¡£¡£¡£CAR-TCRÅ·ÖÞ·å»áµÄ½²»°ÕßÒ»ÖÂÒÔΪ£¬£¬Í¨¹ý½ÓÄɹرÕ×Ô¶¯»¯ÏµÍ³ºÍ±ê×¼»¯ÓëÓÅ»¯Õ½ÂÔ£¬£¬ÖÆÔìÉÌ¿ÉÒÔսʤÏÖÓÐÌôÕ½£¬£¬ÊµÏÖCAR Tϸ°ûÁÆ·¨µÄÀå¸ïDZÁ¦¡£¡£¡£¡£
ÔĶÁ¸ü¶à
2024-07-01
Ү³´óѧÑо¿ÍŶÓʹÓÃÌåÄÚAAV-˯ÓÈÎïCRISPRɸѡÊÖÒÕ£¬£¬·¢Ã÷NKϸ°û°©Ö¢ÃâÒßÖÎÁÆÐ°еã
Ү³´óѧ³Â˹µÏ¡¢ÄϾ©´óѧҶ¶ÅôµÈÔÚ?Nature Biotechnology?ÆÚ¿¯½ÒÏþÁËÌâΪ£ºIn vivo AAV¨CSB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy?µÄÑо¿ÂÛÎÄ¡£¡£¡£¡£¸ÃÑо¿·¢Ã÷ÁËÒ»¸öNKϸ°ûµÄȫмì²éµã¡ª¡ªCALHM2£¬£¬²¢Õ¹Ê¾ÁËͨ¹ýÇóýCALHM2À´¹¹½¨ÔöÇ¿ÐÍNKϸ°ûÁÆ·¨µÄDZÁ¦¡£¡£¡£¡£
ÔĶÁ¸ü¶à
¡¾ÍøÕ¾µØÍ¼¡¿